AR049706A1 - Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos - Google Patents
Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usosInfo
- Publication number
- AR049706A1 AR049706A1 ARP050102804A ARP050102804A AR049706A1 AR 049706 A1 AR049706 A1 AR 049706A1 AR P050102804 A ARP050102804 A AR P050102804A AR P050102804 A ARP050102804 A AR P050102804A AR 049706 A1 AR049706 A1 AR 049706A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrogen
- alkyl
- pirrol
- understanding
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Abstract
Se proveen derivados de pirrol-oxindol utiles como antagonistas del receptor de progesterona, y métodos para prepararlos. Se describen composiciones farmacéuticas que contienen estos derivados, como el uso de las mismas en anticoncepcion y afecciones relacionadas con hormonas. Reivindicacion 1: Un compuesto de formula (1), en el cual: R1 es hidrogeno, alquilo, alquilo sustituido, cicloalquilo, alquenilo C3-6, o alquinilo C3-6; R2 y R3 se seleccionan, cada uno en forma independiente, del grupo formado por hidrogeno, alquilo y alquilo sustituido; o R2 y R3 se toman juntos para formar un anillo y juntos contienen -CH2-(CH2)n-CH2-; n es 0, 1, 2 o 3; R4 es hidrogeno o halogeno; R5 es hidrogeno; R6 es hidrogeno o halogeno; R7 es hidrogeno, alquilo o halogeno; R8 es hidrogeno; R9 es hidrogeno, alquilo, alquilo sustituido o COORA; RA es alquilo o alquilo sustituido; o una de sus sales aceptables desde el punto de vista farmacéutico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60003104P | 2004-08-09 | 2004-08-09 | |
US67168405P | 2005-04-15 | 2005-04-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049706A1 true AR049706A1 (es) | 2006-08-30 |
Family
ID=34979790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050102804A AR049706A1 (es) | 2004-08-09 | 2005-07-06 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos |
Country Status (20)
Country | Link |
---|---|
US (2) | US7317037B2 (es) |
EP (1) | EP1776107A1 (es) |
JP (1) | JP2008509217A (es) |
KR (1) | KR20070039567A (es) |
AR (1) | AR049706A1 (es) |
AU (1) | AU2005277881A1 (es) |
BR (1) | BRPI0514180A (es) |
CA (1) | CA2573314A1 (es) |
CR (1) | CR8847A (es) |
EC (1) | ECSP077233A (es) |
GT (1) | GT200500185A (es) |
IL (1) | IL181043A0 (es) |
MX (1) | MX2007001608A (es) |
NO (1) | NO20070742L (es) |
PA (1) | PA8638801A1 (es) |
PE (1) | PE20060486A1 (es) |
RU (1) | RU2007101303A (es) |
SV (1) | SV2006002167A (es) |
TW (1) | TW200607798A (es) |
WO (1) | WO2006023109A1 (es) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
JP5288796B2 (ja) | 2004-07-07 | 2013-09-11 | ワイス・エルエルシー | 周期的プロゲスチンレジメン及びキット |
GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
GT200500183A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
MY144968A (en) | 2005-04-11 | 2011-11-30 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
MY145694A (en) | 2005-04-11 | 2012-03-30 | Xenon Pharmaceuticals Inc | Spiroheterocyclic compounds and their uses as therapeutic agents |
ES2340518T3 (es) * | 2005-04-28 | 2010-06-04 | Wyeth Llc | Tanaproget micronizado y composiciones que lo contienen. |
AU2006287925B2 (en) | 2005-04-28 | 2012-03-01 | Wyeth | Compositions containing micronized tanaproget |
CN101166532B (zh) | 2005-04-28 | 2011-06-22 | 惠氏公司 | 微粒化的他那普戈特、组合物及其制备方法 |
PE20070404A1 (es) * | 2005-07-29 | 2007-05-10 | Wyeth Corp | Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona |
PE20070182A1 (es) | 2005-07-29 | 2007-03-06 | Wyeth Corp | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona |
PE20070220A1 (es) | 2005-07-29 | 2007-03-19 | Wyeth Corp | Proceso para la sintesis de moduladores del receptor de progesterona |
PE20070341A1 (es) * | 2005-07-29 | 2007-04-13 | Wyeth Corp | Derivados de pirrol como moduladores del receptor de progesterona |
US20070213526A1 (en) * | 2006-03-07 | 2007-09-13 | Wyeth | Purification of progesterone receptor modulators |
WO2008021309A1 (en) * | 2006-08-15 | 2008-02-21 | Wyeth | Imidazolidin-2-one derivatives useful as pr modulators |
WO2008021422A2 (en) * | 2006-08-17 | 2008-02-21 | Wyeth | Process for the preparation of indolin-2-one derivatives useful as pr modulators |
WO2008060789A2 (en) | 2006-10-12 | 2008-05-22 | Xenon Pharmaceuticals Inc. | Use of spiro-oxindole compounds as therapeutic agents |
TW200848021A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Sulfonylated heterocycles useful for modulation of the progesterone receptor |
WO2008153674A1 (en) * | 2007-06-09 | 2008-12-18 | Boris Kobrin | Method and apparatus for anisotropic etching |
US20080312306A1 (en) * | 2007-06-15 | 2008-12-18 | Wyeth | Polymorphs, solvates, and hydrate of 5-(4'-fluoro-2'-oxo-1',2'-dihydrospiro[cyclopropane-1,3'-indol]-5'-yl)-1-methyl-1h-pyrrole-2-carbonitrile |
US20080319204A1 (en) * | 2007-06-25 | 2008-12-25 | Wyeth | Process for the synthesis of progesterone receptor modulators |
TWI477276B (zh) * | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
EP2350091B1 (en) | 2008-10-17 | 2015-06-03 | Xenon Pharmaceuticals Inc. | Spiro-oxindole compounds and their use as therapeutic agents |
SG10201703086VA (en) | 2008-10-17 | 2017-05-30 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their use as therapeutic agents |
CN101417945B (zh) * | 2008-10-23 | 2012-05-23 | 浙江工业大学 | 4-溴-2,3,5,6-四氟苯乙酸的制备方法 |
AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
RU2544852C2 (ru) | 2009-10-14 | 2015-03-20 | Ксенон Фармасьютикалз Инк. | Способы синтеза спиро-оксиндольных соединений |
US9504671B2 (en) | 2010-02-26 | 2016-11-29 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
NZ702467A (en) | 2012-05-31 | 2016-07-29 | Repros Therapeutics Inc | Formulations and methods for vaginal delivery of antiprogestins |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
CA2888377C (en) | 2012-11-02 | 2021-02-02 | Repros Therapeutics Inc. | Methods and compositions for treating progesterone-dependent conditions |
EP2730284A1 (en) * | 2012-11-12 | 2014-05-14 | Naari AG | Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
JP6301076B2 (ja) * | 2013-07-11 | 2018-03-28 | キヤノンメディカルシステムズ株式会社 | 核医学診断装置および画像処理プログラム |
AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
CN105294659A (zh) * | 2014-07-01 | 2016-02-03 | 中国科学院成都有机化学有限公司 | 3,3’-二取代的3-吡咯氧化吲哚化合物及其不对称合成方法 |
TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
CN107835814B (zh) | 2015-04-29 | 2021-07-23 | 詹森药业有限公司 | 氮杂苯并咪唑及其作为ampa受体调节剂的用途 |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
RU2601749C1 (ru) * | 2015-09-08 | 2016-11-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный технический университет" (ВолгГТУ) | Способ получения 4'-фторспиро[циклопропан-1,3'-индол]-2'(1'н)-она |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US9797043B1 (en) * | 2016-09-13 | 2017-10-24 | Rohm And Haas Electronic Materials Llc | Shielding coating for selective metallization |
CN110845390B (zh) * | 2019-11-26 | 2023-04-07 | 郑州师范学院 | 一种3-氟氧化吲哚衍生物的制备方法 |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
US11679114B2 (en) | 2021-07-26 | 2023-06-20 | Navad Life Sciences Pte | Progestogen-only oral contraception |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9103752D0 (sv) | 1991-12-18 | 1991-12-18 | Astra Ab | New compounds |
SE9302080D0 (sv) | 1993-06-16 | 1993-06-16 | Ab Astra | New compounds |
DK1123289T3 (da) | 1998-10-22 | 2003-03-17 | Ciba Sc Holding Ag | Oxobenzofuranyliden-dihydroindoloner |
US6509334B1 (en) | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
US6462032B1 (en) * | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
US6355648B1 (en) * | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
US6444668B1 (en) | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
AU2002231098A1 (en) | 2000-12-15 | 2002-06-24 | Emory University | Nonpeptide agonists and antagonists of vasopressin receptors |
US7102000B2 (en) | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
US7196108B2 (en) | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
JP2005527553A (ja) | 2002-03-29 | 2005-09-15 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | 自己免疫疾患の治療におけるスタチン類および他の自己免疫調節剤の利用 |
MXPA04012419A (es) | 2002-06-25 | 2005-04-19 | Wyeth Corp | Uso de derivados de tio-oxindol en el tratamiento de condiciones relacionadas con la hormona. |
WO2004000227A2 (en) | 2002-06-25 | 2003-12-31 | Wyeth | Use of thio-oxindole derivatives in treatment of skin disorders |
AU2003286594A1 (en) | 2002-10-21 | 2004-05-13 | Irm Llc | Quinolones with anti-hiv activity |
WO2004037247A1 (en) | 2002-10-21 | 2004-05-06 | Irm Llc | Oxindoles with anti-hiv activity |
AU2003267801A1 (en) | 2002-10-28 | 2004-05-13 | Warner-Lambert Company Llc | Oxindole substituted piperazine derivatives |
CN1784363A (zh) * | 2003-04-01 | 2006-06-07 | 康宁股份有限公司 | 灯光反射器基材,玻璃、玻璃陶瓷材料以及它们的制造方法 |
ATE413398T1 (de) | 2004-04-08 | 2008-11-15 | Wyeth Corp | Thioamidderivate als progesteronrezeptormodulatoren |
FR2868775B1 (fr) | 2004-04-13 | 2008-04-11 | Servier Lab | Nouveau procede de synthese de derives de la 1,3,4,5- tetrahydro-2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable |
CN1953967B (zh) | 2004-04-27 | 2013-03-13 | 惠氏公司 | 孕酮受体调节剂的纯化 |
TW200604137A (en) | 2004-04-27 | 2006-02-01 | Wyeth Corp | Coupling process for generating reactive boron-containing derivatives of n-substituted pyrrole-2-carbonitriles to produce biaryls |
US20050261327A1 (en) | 2004-05-20 | 2005-11-24 | Bock Mark G | 2-(Bicyclo)alkylamino-derivatives as mediatores of chronic pain and inflammation |
JP5288796B2 (ja) * | 2004-07-07 | 2013-09-11 | ワイス・エルエルシー | 周期的プロゲスチンレジメン及びキット |
GT200500186A (es) * | 2004-07-07 | 2006-03-02 | Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits | |
GT200500183A (es) | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
JP2008515980A (ja) | 2004-10-12 | 2008-05-15 | デコード ジェネティクス イーエイチエフ | 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物 |
-
2005
- 2005-07-04 GT GT200500185A patent/GT200500185A/es unknown
- 2005-07-06 KR KR1020077002009A patent/KR20070039567A/ko not_active Application Discontinuation
- 2005-07-06 SV SV2005002167A patent/SV2006002167A/es not_active Application Discontinuation
- 2005-07-06 CA CA002573314A patent/CA2573314A1/en not_active Abandoned
- 2005-07-06 US US11/175,824 patent/US7317037B2/en active Active
- 2005-07-06 BR BRPI0514180-0A patent/BRPI0514180A/pt not_active Application Discontinuation
- 2005-07-06 AR ARP050102804A patent/AR049706A1/es unknown
- 2005-07-06 MX MX2007001608A patent/MX2007001608A/es not_active Application Discontinuation
- 2005-07-06 TW TW094122832A patent/TW200607798A/zh unknown
- 2005-07-06 EP EP05771115A patent/EP1776107A1/en not_active Withdrawn
- 2005-07-06 AU AU2005277881A patent/AU2005277881A1/en not_active Abandoned
- 2005-07-06 PE PE2005000785A patent/PE20060486A1/es not_active Application Discontinuation
- 2005-07-06 JP JP2007525616A patent/JP2008509217A/ja active Pending
- 2005-07-06 RU RU2007101303/04A patent/RU2007101303A/ru unknown
- 2005-07-06 PA PA20058638801A patent/PA8638801A1/es unknown
- 2005-07-06 WO PCT/US2005/023795 patent/WO2006023109A1/en active Application Filing
-
2007
- 2007-01-11 CR CR8847A patent/CR8847A/es not_active Application Discontinuation
- 2007-01-29 IL IL181043A patent/IL181043A0/en unknown
- 2007-02-08 NO NO20070742A patent/NO20070742L/no not_active Application Discontinuation
- 2007-02-09 EC EC2007007233A patent/ECSP077233A/es unknown
- 2007-11-16 US US11/985,606 patent/US20080114050A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ECSP077233A (es) | 2007-03-29 |
PA8638801A1 (es) | 2006-06-02 |
AU2005277881A1 (en) | 2006-03-02 |
JP2008509217A (ja) | 2008-03-27 |
IL181043A0 (en) | 2007-07-04 |
RU2007101303A (ru) | 2008-09-20 |
CR8847A (es) | 2007-08-28 |
US7317037B2 (en) | 2008-01-08 |
MX2007001608A (es) | 2007-04-10 |
SV2006002167A (es) | 2006-03-15 |
US20080114050A1 (en) | 2008-05-15 |
GT200500185A (es) | 2006-04-10 |
PE20060486A1 (es) | 2006-07-06 |
NO20070742L (no) | 2007-05-07 |
BRPI0514180A (pt) | 2008-06-03 |
WO2006023109A1 (en) | 2006-03-02 |
EP1776107A1 (en) | 2007-04-25 |
KR20070039567A (ko) | 2007-04-12 |
US20060030717A1 (en) | 2006-02-09 |
CA2573314A1 (en) | 2006-03-02 |
TW200607798A (en) | 2006-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR049706A1 (es) | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
AR049708A1 (es) | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
AR081577A1 (es) | Derivados de aminopirimidina como moduladores de la lrrk2 | |
AR127309A2 (es) | Derivados de piridazinona | |
PE20060590A1 (es) | COMPUESTOS ESTEROIDALES 15ß-SUSTITUIDOS CON ACTIVIDAD SELECTIVA DEL RECEPTOR DE ESTROGENOS | |
AR047744A1 (es) | Compuestos de triazol y su uso como antagonistas del receptor de glutamato metabotropico | |
AR056511A1 (es) | Derivados de 2-aminopirimidinas, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por el receptor de histamina h4 | |
PE20180929A1 (es) | Analogos novedosos de nucleosidos sustituidos en el anillo aromatico biciclico 6-6 para su uso como inhibidores de prmt5 | |
PE20080263A1 (es) | Compuestos de pirrolo-pirimidina y sus usos | |
AR050274A1 (es) | Derivados triciclicos del indeno-pirrol como moduladores de la serotonina | |
AR076460A1 (es) | Antagonistas del receptor cxcr3 | |
AR088029A1 (es) | Compuestos de pirimidina sustituidos, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento del dolor, accidentes cerebrovasculares, epilepsia y otras enfermedades del sistema nervioso central | |
AR052943A1 (es) | Derivados de 2-(4-oxo-4h-quinazolin-3-il)acetamida | |
PA8546601A1 (es) | Nuevos derivados de indol con afinidad por el receptor 5-ht6 | |
UY28526A1 (es) | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos | |
AR063147A1 (es) | Compuestos heterociclicos nitrogenados inhibidores de receptores de histamina h3, metodo de preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de trastornos del sistema nervioso central. | |
PE20080182A1 (es) | Derivados pirrolo-quinoxalinona como antibacterianos | |
PE20070642A1 (es) | Compuestos derivados de pirazol como antagonistas del receptor de la progesterona | |
AR060050A1 (es) | Compuestos moduladores del receptor de s1p y uso de los mismos | |
AR054786A1 (es) | (6-fluor-benzol(1,3) dioxolil)-morfolin-4-il-metanomas, moduladoras del receptor cb1 | |
PE20011371A1 (es) | Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5 | |
AR049696A1 (es) | Derivados de indol | |
PE20200665A1 (es) | Compuestos espirociclicos y sus metodos de preparacion y uso | |
AR079205A1 (es) | Morfolinotiazoles como moduladores alostericos positivos alfa 7 | |
AR076401A1 (es) | Bisaril alquinilamidas como moduladores alostericos negativos del receptor metabotropico de glutamato 5 (mglur5) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |